At present, there are no specific nationwide epidemiological studies representing the whole Italian population. This study is aimed at describing the epidemiological and economic burden that HCV will generate in the next few years in Italy. Furthermore, the impact that future anti-HCV treatments may have on the burden of disease was considered. This analysis was developed for the period 2012-2030 from the perspective of the Italian National Health Service (NHS)
Objective: We estimated the cost consequence of Italian National Health System (NHS) investment in d...
Background and aims. Hepatitis C virus (HCV) elimination for Italy is an ambitious, but achievable g...
Abstract: Between western European countries, the hepatitis C virus (HCV) endemic is highest in Ital...
At present, there are no specific nationwide epidemiological studies representing the whole Italian ...
Aim To evaluate the cost-consequences of the investment for anti-hepatitis C virus (HCV) treatment b...
Background: Hepatitis C virus (HCV) affects an estimated number of people between 130 million and 21...
Objective: We estimated the cost consequence of Italian National Health System (NHS) investment in d...
Background and aims. Hepatitis C virus (HCV) elimination for Italy is an ambitious, but achievable g...
Abstract: Between western European countries, the hepatitis C virus (HCV) endemic is highest in Ital...
At present, there are no specific nationwide epidemiological studies representing the whole Italian ...
Aim To evaluate the cost-consequences of the investment for anti-hepatitis C virus (HCV) treatment b...
Background: Hepatitis C virus (HCV) affects an estimated number of people between 130 million and 21...
Objective: We estimated the cost consequence of Italian National Health System (NHS) investment in d...
Background and aims. Hepatitis C virus (HCV) elimination for Italy is an ambitious, but achievable g...
Abstract: Between western European countries, the hepatitis C virus (HCV) endemic is highest in Ital...